Thermon Group (THR) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.36 per share. This compares to earnings of $0.38 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +52.78%. A quarter ago, it was expected that this maker of heat tracing products would post earnings of $0.37 per share when it actually produced earnings of $0.36, delivering a surprise of -2.7%.Over the last four qu ...

Tapestry (TPR) came out with quarterly earnings of $1.38 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $1.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +10.40%. A quarter ago, it was expected that this maker of high-end shoes and handbags would post earnings of $1.01 per share when it actually produced earnings of $1.04, delivering a surprise of +2.97%.Over the last four ...

Warby Parker Inc. (WRBY) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.05 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +22.22%. A quarter ago, it was expected that this company would post earnings of $0.08 per share when it actually produced earnings of $0.08, delivering no surprise.Over the last four quarters, the company has su ...

Target Hospitality (TH) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to earnings of $0.2 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +75.00%. A quarter ago, it was expected that this company would post a loss of $0.11 per share when it actually produced a loss of $0.15, delivering a surprise of -36.36%.Over the last four quarters, the company has su ...

Oil prices edged up on Thursday, boosted by concerns over supply as sanctions on Russian oil weighed on sentiments. Meanwhile, gold prices were back above the coveted $4,000-per-ounce mark after a fe... ...

NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX) between February 23, 2022 and July 30, 2025, inclusive. Should You Join This Class Action Lawsuit? Do you, or did you, own shares of Baxter International Inc. (NYSE: BAX)?Did you purchase your shares between February 23, 20 ...

FORT LAUDERDALE, Fla., Nov. 6, 2025 /PRNewswire/ -- Today, HoldCo Asset Management, LP ("HoldCo"), a Florida-based investment firm managing approximately $2.6 billion in regulatory assets under management, released a presentation to First Interstate BancSystem, Inc. entitled "Respect To The Board."The presentation may be found at the following link:https://holdcoam.co/FIBK_Nov6In the presentation, HoldCo disclosed that it owns common stock of First Interstate BancSystem, Inc. (NASDAQ Global Select Market: F ...

Accessibility StatementSkip Navigation FORT LAUDERDALE, Fla., Nov. 6, 2025 /PRNewswire/ -- Today, HoldCo Asset Management, LP ("HoldCo"), a Florida-based investment firm managing approximately $2.6 billion in regulatory assets under management, released a presentation to First Interstate BancSystem, Inc. entitled "Respect To The Board." The presentation may be found at the following link: Continue Reading View PDF Respect To The Board https://holdcoam.co/FIBK_Nov6 In the presentation, HoldCo disclosed that ...

In-Vitro Data Confirms Strong Protection Against H1N1 Influenza via Physical Barrier Mechanism Ra’anana, Israel, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company developing intranasal products based on its proprietary Capture & Contain (C&C) platform, today announced positive in-vitro results for its product candidate, the PL-16 Viral Blocker, a proprietary nasal gel formulation, confirming a broad-spectrum viral blocking efficacy and re ...

Joining me now to preview results coming from a firm is Matt Tuttle, CEO and CIO of Tuttle Capital Management. Matt, it's good to see you this morning. You say uh in terms of a firm, the way you should look at it is this is a check on the consumer.Uh do you still see it that way. >> I I do. Um you know, and and Bloomberg actually came out with an article on this this morning kind of talking about the economy as like a Jenga game.I I think you've got this massive dichotomy between the halves and the have not ...